Jangomolide is primarily used in research settings for its potential anti-inflammatory and neuroprotective properties. It has shown promise in preclinical studies for modulating cellular pathways involved in oxidative stress and neuronal damage, making it a candidate of interest in the development of therapies for neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. Its ability to cross the blood-brain barrier enhances its utility in central nervous system-related studies. Additionally, jangomolide is investigated for its role in inhibiting specific kinases involved in tumor progression, suggesting possible applications in oncology research. Due to its natural origin and structural complexity, it also serves as a lead compound in the synthesis of derivatives with improved bioavailability and target specificity.